Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global EGFR Mutation Test Market by Type (DNA Sequencing, Kits), By Application (Cancer Hospitals, Clinical Research Institutes) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global EGFR Mutation Test Market by Type (DNA Sequencing, Kits), By Application (Cancer Hospitals, Clinical Research Institutes) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 137777 3300 Medical Devices & Consumables 377 231 Pages 4.6 (50)

Market Overview:

The global EGFR mutation test market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of cancer, rising demand for personalized medicine, and technological advancements in DNA sequencing and kits. Based on type, the global EGFR mutation test market is segmented into DNA sequencing and kits. The DNA sequencing segment is further sub-segmented into next-generation sequencing (NGS) and Sanger sequencing. The kit segment is further sub-segmented into polymerase chain reaction (PCR) kits and ligase chain reaction (LCR) kits. Based on application, the global EGFR mutation test market is divided into cancer hospitals and clinical research institutes. Geographically, the global EGFR mutation test market has been segregated into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .

Global EGFR Mutation Test Industry Outlook

Product Definition:

EGFR mutation test is a laboratory test that can detect specific gene mutations in the epidermal growth factor receptor (EGFR) gene. The EGFR mutation test is used to help diagnose non-small cell lung cancer (NSCLC) and determine how well the cancer will respond to treatment with certain medications.

DNA Sequencing:

DNA sequencing is a process of determining the sequence of nucleotides (base pairs) in DNA. It is used for identifying and analyzing genetic abnormalities, such as mutations or gene duplications. The test uses a sample (biopsy or blood) for testing purposes to analyze the presence of specific genes that may be causing cancer.


Kits are reagents and instruments that help in detecting the presence of a specific gene mutation by providing accurate and effective results. Kits used for testing include Transcription-mediated Amplification Test (TMAT) and Polymerase Chain Reaction (PCR)-based test. TMAT is considered as one of the most popular methods used for detection of exon 17 mutations, while PCR-based test is widely accepted as an accurate method to detect EGFR mutation in tumor tissue or blood samples.

Application Insights:

The cancer hospitals segment dominated the market in 2017. This is attributed to presence of key players such as Foundation Medicine and OncoGenex that offer a wide range of testing options for patients with suspected genetic mutations. In addition, growing adoption of these tests by leading global healthcare companies for clinical research purposes is expected to drive the growth over the forecast period.

Clinical research institutes are anticipated to register significant growth over the forecast period owing to increasing government funding and initiatives aimed at supporting biopharmaceutical companies conducting clinical trials in emerging markets such as India, China and Brazil. In addition, favorable reimbursement policies coupled with rising awareness about advanced treatments are expected fuel industry expansion over the next eight years.

Other applications include carrier screening & prenatal testing which accounted for 10% share in 2017 due largely to introduction of new technologies that have led towards increased accuracy rates while diagnosing rare diseases & disorders associated with an EGFR mutation or no mutation respectively.

Regional Analysis:

North America dominated the global market in 2017. This can be attributed to the presence of a well-established healthcare infrastructure, high adoption of advanced diagnostic technologies, and increasing number of clinical studies that require EGFR mutation testing. Moreover, an increase in FDA approvals for new molecular diagnostics tests is also expected to boost the North American market during the forecast period.

The Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to rising investments by governments and private organizations in developing economies such as China & India for improving healthcare facilities coupled with growing awareness about early diagnosis among patients resulting into higher adoption rates for molecular tests. In addition, rapidly expanding medical tourism industry due to lower treatment costs coupled with favorable government policies promoting quality health care services are some other factors contributing toward regional growth rate during this period.

Growth Factors:

  • Increasing incidence of EGFR mutation in various types of cancer
  • Rising demand for personalized medicine and targeted therapies
  • Growing awareness about the benefits of EGFR mutation testing
  • Technological advancements in molecular diagnostics field
  • Proliferation of private diagnostic laboratories

Scope Of The Report

Report Attributes

Report Details

Report Title

EGFR Mutation Test Market Research Report

By Type

DNA Sequencing, Kits

By Application

Cancer Hospitals, Clinical Research Institutes

By Companies

Abbott, Merck, Thermo Fisher Scientific, Illumina, BioMerieux, QIAGEN, Agilent Technologies, Hologic, Novartis, Roche, Genomic Health

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global EGFR Mutation Test Market Report Segments:

The global EGFR Mutation Test market is segmented on the basis of:


DNA Sequencing, Kits

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Cancer Hospitals, Clinical Research Institutes

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Abbott
  2. Merck
  3. Thermo Fisher Scientific
  4. Illumina
  5. BioMerieux
  7. Agilent Technologies
  8. Hologic
  9. Novartis
  10. Roche
  11. Genomic Health

Global EGFR Mutation Test Market Overview

Highlights of The EGFR Mutation Test Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. DNA Sequencing
    2. Kits
  1. By Application:

    1. Cancer Hospitals
    2. Clinical Research Institutes
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the EGFR Mutation Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global EGFR Mutation Test Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

EGFR mutation test is a laboratory test that detects the presence of an EGFR mutation. A mutation occurs when the normal sequence of DNA in a cell is changed. Mutations can cause abnormal growth and development in cells, which may lead to cancer.

Some of the major players in the egfr mutation test market are Abbott, Merck, Thermo Fisher Scientific, Illumina, BioMerieux, QIAGEN, Agilent Technologies, Hologic, Novartis, Roche, Genomic Health.

The egfr mutation test market is expected to grow at a compound annual growth rate of 10.8%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. EGFR Mutation Test Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. EGFR Mutation Test Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. EGFR Mutation Test Market - Supply Chain
   4.5. Global EGFR Mutation Test Market Forecast
      4.5.1. EGFR Mutation Test Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. EGFR Mutation Test Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. EGFR Mutation Test Market Absolute $ Opportunity

5. Global EGFR Mutation Test Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. EGFR Mutation Test Market Size and Volume Forecast by Type
      5.3.1. DNA Sequencing
      5.3.2. Kits
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global EGFR Mutation Test Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. EGFR Mutation Test Market Size and Volume Forecast by Application
      6.3.1. Cancer Hospitals
      6.3.2. Clinical Research Institutes
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global EGFR Mutation Test Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. EGFR Mutation Test Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global EGFR Mutation Test Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. EGFR Mutation Test Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global EGFR Mutation Test Demand Share Forecast, 2019-2029

9. North America EGFR Mutation Test Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America EGFR Mutation Test Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America EGFR Mutation Test Market Size and Volume Forecast by Application
      9.4.1. Cancer Hospitals
      9.4.2. Clinical Research Institutes
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America EGFR Mutation Test Market Size and Volume Forecast by Type
      9.7.1. DNA Sequencing
      9.7.2. Kits
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America EGFR Mutation Test Demand Share Forecast, 2019-2029

10. Latin America EGFR Mutation Test Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America EGFR Mutation Test Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America EGFR Mutation Test Market Size and Volume Forecast by Application
      10.4.1. Cancer Hospitals
      10.4.2. Clinical Research Institutes
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America EGFR Mutation Test Market Size and Volume Forecast by Type
      10.7.1. DNA Sequencing
      10.7.2. Kits
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America EGFR Mutation Test Demand Share Forecast, 2019-2029

11. Europe EGFR Mutation Test Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe EGFR Mutation Test Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe EGFR Mutation Test Market Size and Volume Forecast by Application
      11.4.1. Cancer Hospitals
      11.4.2. Clinical Research Institutes
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe EGFR Mutation Test Market Size and Volume Forecast by Type
      11.7.1. DNA Sequencing
      11.7.2. Kits
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Gowth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe EGFR Mutation Test Demand Share, 2019-2029

12. Asia Pacific EGFR Mutation Test Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific EGFR Mutation Test Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific EGFR Mutation Test Market Size and Volume Forecast by Application
      12.4.1. Cancer Hospitals
      12.4.2. Clinical Research Institutes
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific EGFR Mutation Test Market Size and Volume Forecast by Type
      12.7.1. DNA Sequencing
      12.7.2. Kits
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific EGFR Mutation Test Demand Share, 2019-2029

13. Middle East & Africa EGFR Mutation Test Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa EGFR Mutation Test Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa EGFR Mutation Test Market Size and Volume Forecast by Application
      13.4.1. Cancer Hospitals
      13.4.2. Clinical Research Institutes
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa EGFR Mutation Test Market Size and Volume Forecast by Type
      13.7.1. DNA Sequencing
      13.7.2. Kits
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa EGFR Mutation Test Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global EGFR Mutation Test Market: Market Share Analysis
   14.2. EGFR Mutation Test Distributors and Customers
   14.3. EGFR Mutation Test Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Abbott Overview Financials Developments Strategic Outlook
      14.4.2. Merck Overview Financials Developments Strategic Outlook
      14.4.3. Thermo Fisher Scientific Overview Financials Developments Strategic Outlook
      14.4.4. Illumina Overview Financials Developments Strategic Outlook
      14.4.5. BioMerieux Overview Financials Developments Strategic Outlook
      14.4.6. QIAGEN Overview Financials Developments Strategic Outlook
      14.4.7. Agilent Technologies Overview Financials Developments Strategic Outlook
      14.4.8. Hologic Overview Financials Developments Strategic Outlook
      14.4.9. Novartis Overview Financials Developments Strategic Outlook
      14.4.10. Roche Overview Financials Developments Strategic Outlook
      14.4.11. Genomic Health Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us